Twist Bioscience 2025年第一季度GAAP每股亏损$(0.53)好于预期$(0.64),销售额为$88.71M超出预测$86.97M

财报速递2025-02-03
Twist Bioscience (NASDAQ:TWST)报告其季度每股亏损为$(0.53),这比分析师预期的$(0.64)高出17.19%。相比去年的每股亏损$(0.75),增加了29.33%。公司报告季度销售额为$88.71百万,超过了分析师预期的$86.97百万,增幅为2.00%。这比去年同期的销售额$71.50百万增加了24.08%。

以上内容来自Benzinga Earnings专栏,原文如下:

Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.64) by 17.19 percent. This is a 29.33 percent increase over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $88.71 million which beat the analyst consensus estimate of $86.97 million by 2.00 percent. This is a 24.08 percent increase over sales of $71.50 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法